Eyevensys raised €25M in a Series B round in Aug 2020. The company is based in Paris, France. Investors in the round: Boehringer Ingelheim Venture Fund. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
